June 3, 2013
- The European Commission has published a revised version of the application form for all marketing-authorisation applications for medicines for human use.
- PRONOUNCE Study Does Not Achieve Primary Superiority Endpoint for ALIMTA® (pemetrexed for injection), Similar PFS and OS Results Were Observed Between the Two Drug and the Three Drug Regimens in the Treatment of NSCLC
- Abbott Previews Next-Generation Blood Screening Prototype during International Society of Blood Transfusion Meeting
Sanofi (EURONEXT: SAN and NYSE: SNY) today announced topline results of two Phase 3 clinical studies of its investigational compounds iniparib and otamixaban respectively.- AstraZeneca today announced it has entered into an agreement with Hanmi Pharmaceutical and affiliates (“Hanmi”) and its US marketing partner Amneal Pharmaceuticals (“Amneal”) to resolve certain issues and appeal others in US Nexium patent litigation regarding Hanmi’s Esomeprazole Strontium 505(b)2 NDA product. The agreement eliminates the need for a trial at the US District Court for the District of New Jersey (“District Court”), thus avoiding considerable trial costs.
- Chicago, IL., June 1, 2013 and Osaka, Japan, June 3, 2013 – Takeda Pharmaceutical Company Limited (TSE:4502) today announced interim data from a Phase 1/2, open-label, multicenter study with ADCETRIS®(brentuximab vedotin) in pediatric patients diagnosed with CD30-positive relapsed
- MyHealthAvatar project aims to proof the concept of the digital representation of your health status. Your health status will be designed as a lifetime companion (Avatar). Your Health Avatar will facilitate the collection of, and access to, long-term health-status information. This will be extremely valuable for healthcare decisions and offer a promising approach to support health research. The Health Avatar is the digital representation of your body with the related processes in a way that...
- LUME-Lung 1 results represent the first advance in almost a decade in overall survival for patients where initial chemotherapy has failed - For non U.S. Media Only
June 2, 2013
- MyHealthAvatar project aims to proof the concept of the digital representation of your health status. Your health status will be designed as a lifetime companion (Avatar). Your Health Avatar will facilitate the collection of, and access to, long-term health-status information. This will be extremely valuable for healthcare decisions and offer a promising approach to support health research.